Librería: NEPO UG, Rüsselsheim am Main, Alemania
EUR 10,99
Cantidad disponible: 1 disponibles
Añadir al carritoGebundene Ausgabe. Condición: Sehr gut. 338 Seiten ex library book aus einer Unternehmensbibliothek Sprache: Englisch Gewicht in Gramm: 550.
Librería: Reader's Corner, Inc., Raleigh, NC, Estados Unidos de America
Original o primera edición
EUR 35,46
Cantidad disponible: 1 disponibles
Añadir al carritoCloth. Condición: Fine. No Jacket. First Edition. This is a fine, unmarked, hardcover first edition copy, blue cloth binding, no DJ.
Librería: NEPO UG, Rüsselsheim am Main, Alemania
EUR 14,91
Cantidad disponible: 1 disponibles
Añadir al carritoGebundene Ausgabe. Condición: Sehr gut. 338 Seiten ex LIbrary 'Book aus einer wissenschaftlichen Bibliothek Sprache: Englisch Gewicht in Gramm: 550.
Idioma: Alemán
Publicado por Basel, Prognos AG., 1976
Librería: Antiquariat Thomas Haker GmbH & Co. KG, Berlin, Alemania
Miembro de asociación: GIAQ
EUR 12,20
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Gut. 172, 63 S., m. Tab., Guter Zustand. Bibliotheksexemplar mit Stempeln und Signatur auf Einband. Sonst Seiten sauber. Papier / Einband alterungsbedingt am Rand leicht vergilbt. Sprache: Deutsch Gewicht in Gramm: 590.
Librería: NEPO UG, Rüsselsheim am Main, Alemania
EUR 36,96
Cantidad disponible: 1 disponibles
Añadir al carritoGebundene Ausgabe. Condición: Sehr gut. 216 Seiten ex LIbrary 'Book aus einer wissenschaftlichen Bibliothek Sprache: Englisch Gewicht in Gramm: 550.
Original o primera edición
EUR 28,58
Cantidad disponible: 1 disponibles
Añadir al carritoHard Cover. Condición: Very Good. No Jacket. First Edition. Lightly worn copy.
Librería: AMAHOFF- Bookstores, Roßtal, Alemania
EUR 30,00
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Sehr gut. Auflage: 1. 240 Seiten Sehr gutes Exemplar 55 9783540505341 Sprache: Englisch Gewicht in Gramm: 626 0,0 x 0,0 x 0,0 cm, Gebundene Ausgabe.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 76,11
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New. pp. xxi + 338 1st Edition.
EUR 72,94
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New. pp. xxi + 338 35 Figures.
EUR 72,78
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New. pp. xxi + 338.
Publicado por Frankfurt [Main] : Bundesverb. d. Pharmazeut. Industrie, 1982
Librería: Roland Antiquariat UG haftungsbeschränkt, Weinheim, Alemania
EUR 9,50
Cantidad disponible: 1 disponibles
Añadir al carritoSoftcover. 19 S. ; 20 x 21 cm Guter Zustand. Leseseiten sind sauber und ohne Markierungen. Ausgeschiedenes Bibliotheksexemplar mit entsprechender Kennzeichnung. Buch weist leichte Lager- bzw. Gebrauchsspuren auf. Sonst gutes Exemplar. Sprache: Deutsch Gewicht in Gramm: 1000.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 114,49
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
EUR 29,90
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product. The issue reaches legislatures and regulatory agencies when consumer advocates seek to influence the standards of drug usage. Front-page news tends to focus on accidents or other risk events with drugs. Drug risk and drug safety have become an important political issue. Drug regulat ory agencies have been instituted, and their responsibility has increased. The approval to market a drug is dependent on a set of sophisticated studies executed according to strict protocols and scientifically defined criteria. Drug surveillance activities have gained recognition, and reporting systems to identify drug safety problems have been strengthened. The understanding and management of drug safety is, nonetheless, beset by doubts, disagreements, and disputes. Conflict occurs over the significance of risk, the adequacy of evidence, the methodologies used to evaluate and measure risk, the standards that guide regulation, and the optimal means of communicating risk information to the public.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 160,35
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. xxiii + 210.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 152,21
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback. Condición: Brand New. reprint edition. 240 pages. 9.40x6.80x0.60 inches. In Stock.
Idioma: Inglés
Publicado por Springer Berlin Heidelberg, 2011
ISBN 10: 3642742742 ISBN 13: 9783642742743
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 106,99
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product. The issue reaches legislatures and regulatory agencies when consumer advocates seek to influence the standards of drug usage. Front-page news tends to focus on accidents or other risk events with drugs. Drug risk and drug safety have become an important political issue. Drug regulat ory agencies have been instituted, and their responsibility has increased. The approval to market a drug is dependent on a set of sophisticated studies executed according to strict protocols and scientifically defined criteria. Drug surveillance activities have gained recognition, and reporting systems to identify drug safety problems have been strengthened. The understanding and management of drug safety is, nonetheless, beset by doubts, disagreements, and disputes. Conflict occurs over the significance of risk, the adequacy of evidence, the methodologies used to evaluate and measure risk, the standards that guide regulation, and the optimal means of communicating risk information to the public.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 162,89
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 198,65
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. xxi + 338.
Idioma: Inglés
Publicado por Springer Berlin Heidelberg, 2011
ISBN 10: 3642647626 ISBN 13: 9783642647628
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 160,49
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - As the focus on pharmaceuticals has broadened from concern for their cost and effectiveness to their real and potential risks and benefits, a critical question has been raised: whose responsibility is it to improve drug safety In April 1990, this question became the theme for a conference at Wolfsberg, Switzerland, near the shores of Lake Constance. Called an 'international dialogue conference' by its organizers, the meeting brought together leaders from the pharmaceutical industry, regulatory authorities, academia, medicine, consumer organizations and the media. Opening addresses were given by representatives of the Council for International Organizations of Medical Sciences (CIOMS), the International Federation of Pharmaceutical Manufacturers Associations (IFPMA), the Swiss International Pharmaceutical Agency, and the RAD-AR Consortium. This book documents the papers presented and discussions held at this conference, which took the topic of risks and benefits of drug therapy one step further to responsibility. It includes a rich menu of issues for those who care about the evaluation of drug therapy, the ethics behind it, the expectations of the patient, and the role of traditional and nontraditional drug safety communica tions. The ideas expressed here come from different parts of the world but relate to common drug safety problems, observations, and scientific assessments; they provide insights into innovative approaches, cautious changes, and desired actions. The papers in this volume are broadly divided into conceptual perspectives (ethics, how the knowledge about drug risks and benefits is generated and appraised, the expectations in drug safety) and operational perspectives (communication, discussion, and action).
Librería: Revaluation Books, Exeter, Reino Unido
EUR 234,98
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback. Condición: Brand New. reprint edition. 359 pages. 9.53x0.82x6.69 inches. In Stock.
Idioma: Alemán
Publicado por Bern ; Frankfurt am Main ; New York ; Paris : Lang, 1989
ISBN 10: 3261041609 ISBN 13: 9783261041609
Librería: Roland Antiquariat UG haftungsbeschränkt, Weinheim, Alemania
EUR 25,00
Cantidad disponible: 1 disponibles
Añadir al carritoBroschiert. 102 S. ; 24 cm Guter Zustand. Leseseiten sind sauber und ohne Markierungen. Ausgeschiedenes Bibliotheksexemplar mit den üblichen Kennzeichnungen. Buch weist leichte Lagerspuren bzw. Gebrauchsspuren auf. Sonst gutes Exemplar. 9783261041609 Sprache: Deutsch Gewicht in Gramm: 200.
Idioma: Alemán
Publicado por Bern ; Frankfurt am Main ; New York ; Paris : Lang, 1990
ISBN 10: 3261043016 ISBN 13: 9783261043016
Librería: Roland Antiquariat UG haftungsbeschränkt, Weinheim, Alemania
EUR 32,00
Cantidad disponible: 1 disponibles
Añadir al carritoKartoniert. 127 S.; 11 Abb., 29 Tab. Sehr guter Zustand. Leseseiten sind sauber und ohne Markierungen. Ausgeschiedenes Bibliotheksexemplar mit den üblichen Kennzeichnungen. Buch weist leichte Lagerspuren auf. Sonst sehr gutes Exemplar. 9783261043016 Sprache: Deutsch Gewicht in Gramm: 500.
Idioma: Alemán
Publicado por Peter Lang International Academic Publishers, 1989
ISBN 10: 3261041609 ISBN 13: 9783261041609
Librería: Mispah books, Redhill, SURRE, Reino Unido
EUR 217,92
Cantidad disponible: 1 disponibles
Añadir al carritopaperback. Condición: Good. Good. Dust Jacket NOT present. CD WILL BE MISSING. . SHIPS FROM MULTIPLE LOCATIONS. book.
Idioma: Alemán
Publicado por Peter Lang International Academic Publishers, 1990
ISBN 10: 3261043016 ISBN 13: 9783261043016
Librería: Mispah books, Redhill, SURRE, Reino Unido
EUR 247,69
Cantidad disponible: 1 disponibles
Añadir al carritopaperback. Condición: Very Good. Very Good. Dust Jacket may NOT BE INCLUDED.CDs may be missing. SHIPS FROM MULTIPLE LOCATIONS. book.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 86,24
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new. Questo è un articolo print on demand.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 126,26
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new. Questo è un articolo print on demand.
Idioma: Inglés
Publicado por Springer Berlin Heidelberg Dez 2011, 2011
ISBN 10: 3642742742 ISBN 13: 9783642742743
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 112,34
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product. The issue reaches legislatures and regulatory agencies when consumer advocates seek to influence the standards of drug usage. Front-page news tends to focus on accidents or other risk events with drugs. Drug risk and drug safety have become an important political issue. Drug regulat ory agencies have been instituted, and their responsibility has increased. The approval to market a drug is dependent on a set of sophisticated studies executed according to strict protocols and scientifically defined criteria. Drug surveillance activities have gained recognition, and reporting systems to identify drug safety problems have been strengthened. The understanding and management of drug safety is, nonetheless, beset by doubts, disagreements, and disputes. Conflict occurs over the significance of risk, the adequacy of evidence, the methodologies used to evaluate and measure risk, the standards that guide regulation, and the optimal means of communicating risk information to the public. 240 pp. Englisch.
Idioma: Inglés
Publicado por Springer Berlin Heidelberg, 2011
ISBN 10: 3642742742 ISBN 13: 9783642742743
Librería: moluna, Greven, Alemania
EUR 92,27
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product.
Librería: Majestic Books, Hounslow, Reino Unido
EUR 164,56
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand pp. xxiii + 210 29 Figures.
Idioma: Inglés
Publicado por Springer, Springer Dez 2011, 2011
ISBN 10: 3642742742 ISBN 13: 9783642742743
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 106,99
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product. The issue reaches legislatures and regulatory agencies when consumer advocates seek to influence the standards of drug usage. Front-page news tends to focus on accidents or other risk events with drugs. Drug risk and drug safety have become an important political issue. Drug regulat ory agencies have been instituted, and their responsibility has increased. The approval to market a drug is dependent on a set of sophisticated studies executed according to strict protocols and scientifically defined criteria. Drug surveillance activities have gained recognition, and reporting systems to identify drug safety problems have been strengthened. The understanding and management of drug safety is, nonetheless, beset by doubts, disagreements, and disputes. Conflict occurs over the significance of risk, the adequacy of evidence, the methodologies used to evaluate and measure risk, the standards that guide regulation, and the optimal means of communicating risk information to the public.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 240 pp. Englisch.